In addition, literature and media offer medical specialists, students and researchers up-to-date and comprehensive information on clinical pictures, diagnostics and therapy.
As the experts in digestive and metabolic medicine and as a family-owned business with a global presence, we focus on developing and marketing innovative medicines to treat a wide range of gastrointestinal disorders like inflammatory bowel disease or eosinophilic esophagitis as well as hepatobiliary disorders such as primary biliary cholangitis.